Gilead (GILD) Gets EU Nod for Breast Cancer Drug, Trodelvy

Published on November 24, 2021

The European Commission grants marketing authorization to Gilead's (GILD) Trodelvy as a monotherapy for the second-line treatment of adults with metastatic triple-negative breast cancer.

Continue reading on website
Other news

How to Separate the Champs From the Chumps in the Hiring Process

November 24, 2021
Ask candidates these 8 essential questions to ensure you find the best fit for the job.

How to Eliminate Imposter Syndrome Stress With One Simple Phrase, According to These First-Time Founders

November 24, 2021
Mina Park and Ricardo Marquez of Crispy Chicken social media agency discuss the launch and growth of their business.